VWF and acute coronary syndrome: Since the GPIbα-VWF interaction is strictly required for thrombogenesis at pathological levels of shear stress, anfibatide may offer an improved risk/benefit ratio compared to αIIbβ3 and VWF antagonists36, particularly in the management and treatment of acute coronary syndromes in which acute occlusion involves pathologically elevated shear stress.